International

Protests, waning patience test U.S. restrictions

Darpan News Desk The Canadian Press, 09 Feb, 2022 10:58 AM

WASHINGTON - Safety measures aimed at curbing the spread of COVID-19 seem to gradually be giving way in parts of the United States.

Massachusetts and New York are the latest Democrat-led states to ease mask mandates, despite evidence that the surge in the Omicron variant is not yet over.

They follow similar announcements this week in New Jersey, California, Connecticut, Delaware and Oregon.

Public health officials, however, remain divided over whether the time has come to begin easing restrictions.

The Centers for Disease Control and Prevention continue to recommend wearing a mask in indoor settings where the risk of transmission is high.

CDC director Dr. Rochelle Walensky says the agency will continue to review and update its guidance based on the latest available science and data.

Prev Next

MORE International ARTICLES

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.